Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
J. Clin. Endocrinol. Metab., Apr;93(4):1238-45 (2008)
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Clin. Endocrinol. (Oxf)., Aug;65(2):178-85 (2006)
Puberty-timing is everything!
J Pediatr Nurs., Apr;20(2):75-82 (2005)
Prader-Willi syndrome: the care and treatment of infants, children, and adults.
Adv Pediatr., 51:409-34 (2004)
Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
Acta Paediatr Suppl., Dec;88(433):115-7 (1999)
Measuring energy costs of leisure activity in adolescents using a CO2 breath test.
Med Sci Sports Exerc., Sep;29(9):1263-8 (1997)
Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Metab. Clin. Exp., Dec;45(12):1514-20 (1996)
Association between mild, routine exercise and improved insulin dynamics and glucose control in obese adolescents.
Int J Sports Med., Jan;17(1):1-6 (1996)
Energy expenditure in adolescents during low intensity, leisure activities.
Med Sci Sports Exerc., Sep;27(9):1311-4 (1995)
Elevated hepatic glucose production in children with cystic fibrosis.
Pediatr. Res., May;37(5):600-5 (1995)
Feeding-induced changes in energy expenditure in children with cystic fibrosis.
JPEN J Parenter Enteral Nutr., 18(6):497-502 (1994 Nov-Dec)
Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis.
Pediatr. Res., Oct;30(4):309-14 (1991)
Bone mass in healthy children: measurement with quantitative DXA.
Radiology., Jun;179(3):735-8 (1991)
Short-term infusion of pancreatic polypeptide: effect on children with Prader-Willi syndrome.
Am. J. Clin. Nutr., Feb;51(2):162-6 (1990)
Short stature and thyroxine-binding globulin excess: improvement with triiodothyronine treatment.
Pediatrics., May;81(5):674-9 (1988)
Temporal relationship of the prolactin-dependent LH-induced LH receptor to the LH stimulus.
J. Cell. Physiol., Jan;134(1):137-42 (1988)
Sex steroid inhibition of LH induction of the LH receptor.
J. Androl., 8(6):393-7 (1987 Nov-Dec)
Characteristics of prolactin-modulated LH induction of LH/hCG receptors. Transient inhibition of receptor induction following prolactin exposure.
J. Androl., 8(6):388-92 (1987 Nov-Dec)
Direct measurement of testosterone in a pediatric center, with use of a radioimmunoassay kit and unextracted serum.
Clin. Chem., Oct;29(10):1796-8 (1983)
Valine-toxic intermittent maple syrup urine disease: a previously unrecognized variant.
Pediatrics., Feb;63(2):286-94 (1979)